170 related articles for article (PubMed ID: 18234104)
1. Role of resistin as a marker of inflammation in systemic lupus erythematosus.
Almehed K; d'Elia HF; Bokarewa M; Carlsten H
Arthritis Res Ther; 2008; 10(1):R15. PubMed ID: 18234104
[TBL] [Abstract][Full Text] [Related]
2. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.
Baker JF; Morales M; Qatanani M; Cucchiara A; Nackos E; Lazar MA; Teff K; von Feldt JM
J Rheumatol; 2011 Nov; 38(11):2369-75. PubMed ID: 21885493
[TBL] [Abstract][Full Text] [Related]
3. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist F; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.
Lertnawapan R; Bian A; Rho YH; Raggi P; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
Lupus; 2012 Mar; 21(3):279-87. PubMed ID: 22072023
[TBL] [Abstract][Full Text] [Related]
5. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis.
Forsblad d'Elia H; Pullerits R; Carlsten H; Bokarewa M
Rheumatology (Oxford); 2008 Jul; 47(7):1082-7. PubMed ID: 18511473
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of osteoporosis in female SLE patients-extended report.
Almehed K; Forsblad d'Elia H; Kvist G; Ohlsson C; Carlsten H
Rheumatology (Oxford); 2007 Jul; 46(7):1185-90. PubMed ID: 17500075
[TBL] [Abstract][Full Text] [Related]
7. Soluble E-cadherin in systemic lupus erythematosus.
Jin T; Almehed K; Zhu Y; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2013 Oct; 40(10):1677-82. PubMed ID: 23996289
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density.
Shevchuk S; Marynych L; Malovana T; Denyshchych L
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37558268
[TBL] [Abstract][Full Text] [Related]
9. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.
Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Jiménez-Herrera EA; León-Vázquez ML; Montiel-Jarquín Á; García-Carrasco M; Cervera R
PLoS One; 2018; 13(6):e0196113. PubMed ID: 29897913
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.
Cramarossa G; Urowitz MB; Su J; Gladman D; Touma Z
Lupus; 2017 Apr; 26(4):365-372. PubMed ID: 27522094
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
13. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
[TBL] [Abstract][Full Text] [Related]
14. Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus.
Lai EL; Huang WN; Chen HH; Chen JP; Chen DY; Hsieh TY; Hung WT; Lai KL; Lin CT; Tang KT; Chen YM; Chen YH
Arch Osteoporos; 2020 Mar; 15(1):54. PubMed ID: 32221755
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
[TBL] [Abstract][Full Text] [Related]
16. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
[TBL] [Abstract][Full Text] [Related]
17. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
[TBL] [Abstract][Full Text] [Related]
19. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
Liu L; Zhang T; Ye Y; Zhang S; Chen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
